Note 10 - Noncontrolling Interest - Clyra Medical (Details Textual)
|
|
1 Months Ended |
3 Months Ended |
12 Months Ended |
66 Months Ended |
|
|
|
Dec. 04, 2024
USD ($)
|
Oct. 31, 2025
USD ($)
$ / shares
shares
|
Jun. 30, 2024
USD ($)
shares
|
Dec. 31, 2024
USD ($)
$ / shares
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2024
USD ($)
$ / shares
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2023
USD ($)
$ / shares
|
Dec. 13, 2022 |
| Payments to Acquire Notes Receivable |
|
|
|
|
$ (0)
|
$ 82,000
|
|
|
|
| Warrants and Rights Outstanding |
|
|
|
|
$ 5,000
|
|
$ 5,000
|
|
|
| Class of Warrant or Right, Issued During Period (in shares) | shares |
|
|
|
|
2,263,160
|
4,127,516
|
|
|
|
| Debt Conversion, Converted Instrument, Amount |
|
|
|
|
$ 250,000
|
$ 0
|
|
|
|
| Stock Issued During Period, Shares, Issued for Services (in shares) | shares |
|
|
|
|
2,807,771
|
1,107,594
|
|
|
|
| Stock Issued During Period, Value, Issued for Services |
|
|
|
|
$ 557,000
|
$ 284,000
|
|
|
|
| Share Price (in dollars per share) | $ / shares |
|
|
|
|
$ 0.18
|
|
$ 0.18
|
$ 0.18
|
|
| Measurement Input, Price Volatility [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding, Measurement Input |
|
|
|
0.64
|
0.72
|
0.64
|
0.72
|
|
|
| Measurement Input, Price Volatility [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding, Measurement Input |
|
|
|
0.87
|
0.73
|
0.87
|
0.73
|
|
|
| Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding, Measurement Input |
|
|
|
0.0415
|
0.0367
|
0.0415
|
0.0367
|
|
|
| Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding, Measurement Input |
|
|
|
0.0538
|
0.0373
|
0.0538
|
0.0373
|
|
|
| Conversion From Convertible Notes to Shares of Clyra Common Stock [Member] |
|
|
|
|
|
|
|
|
|
| Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares |
|
|
|
|
41,667
|
|
|
|
|
| Convertion of Debt to Shares of Clyra Common Stock [Member] |
|
|
|
|
|
|
|
|
|
| Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares |
|
|
148,156
|
|
|
|
|
|
|
| Debt Conversion, Converted Instrument, Amount |
|
|
$ 741,000
|
|
|
|
|
|
|
| Clyra Medical [Member] |
|
|
|
|
|
|
|
|
|
| Shares, Outstanding (in shares) | shares |
|
|
|
10,544,527
|
11,375,860
|
10,544,527
|
11,375,860
|
|
|
| Shares Issued, Price Per Share (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
$ 3.1
|
|
| Stock Issued During Period, Shares, New Issues (in shares) | shares |
|
|
|
|
72,244
|
373,875
|
|
|
|
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares |
|
|
|
441,336
|
|
441,336
|
|
|
|
| Proceeds from Issuance or Sale of Equity |
|
|
|
|
$ 445,000
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) | shares |
|
|
|
|
1,036,829
|
497,942
|
|
|
|
| Finance Lease, Liability |
|
|
|
|
$ 360,000
|
|
$ 360,000
|
|
|
| Clyra Medical [Member] | Vendors [Member] |
|
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding |
|
|
|
$ 7,000
|
|
$ 7,000
|
|
|
|
| Stock Issued During Period, Shares, Issued for Services (in shares) | shares |
|
|
|
|
37,582
|
11,331
|
|
|
|
| Stock Issued During Period, Value, Issued for Services |
|
|
|
|
$ 100,000
|
$ 29,000
|
|
|
|
| Clyra Medical [Member] | Employees and Consultants [Member] |
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) | shares |
|
|
|
|
1,036,829
|
497,942
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year) |
|
|
|
|
10 years
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Fair Value |
|
|
|
|
$ 1,760,000
|
$ 528,000
|
|
|
|
| Clyra Medical [Member] | Employees and Consultants [Member] | Options With the Exercise Price of 4.5 [Member] |
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) | shares |
|
|
|
|
965,930
|
|
|
|
|
| Clyra Medical [Member] | Employees and Consultants [Member] | Options With the Exercise Price of 3.1 [Member] |
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) | shares |
|
|
|
|
70,899
|
|
|
|
|
| Clyra Medical [Member] | Employees and Consultants [Member] | Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
|
|
|
|
|
| Share Price (in dollars per share) | $ / shares |
|
|
|
$ 3.1
|
$ 4.5
|
$ 3.1
|
$ 4.5
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount Rate |
|
|
|
|
30.00%
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum |
|
|
|
|
3.48%
|
3.95%
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum |
|
|
|
|
4.45%
|
4.34%
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum |
|
|
|
|
21.00%
|
43.00%
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum |
|
|
|
|
49.00%
|
49.00%
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year) |
|
|
|
|
|
10 years
|
|
|
|
| Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|
|
|
|
$ 1,490,000
|
|
$ 1,490,000
|
|
|
| Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year) |
|
|
|
|
3 years
|
|
|
|
|
| Clyra Medical [Member] | Series A Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
| Shares, Outstanding (in shares) | shares |
|
|
|
746,418
|
746,418
|
746,418
|
746,418
|
|
|
| Preferred Stock, Dividend Rate, Percentage |
|
|
|
|
15.00%
|
|
|
|
|
| Preferred Stock, Convertible, Sale of Stock Amount |
|
|
|
|
|
|
|
$ 5,000,000
|
|
| Clyra Medical [Member] | Series B Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
| Shares, Outstanding (in shares) | shares |
|
|
|
|
330,000
|
|
330,000
|
|
|
| Clyra Medical [Member] | Sale Leaseback of Equipment [Member] |
|
|
|
|
|
|
|
|
|
| Receivable with Imputed Interest, Effective Yield (Interest Rate) |
15.00%
|
|
|
|
|
|
|
|
|
| Proceeds from Sale of Property, Plant, and Equipment |
$ 350,000
|
|
|
|
|
|
|
|
|
| Financing Receivable, after Allowance for Credit Loss |
82,000
|
|
|
|
|
|
|
|
|
| Lessee, Finance Lease, Purchase Option, Amount |
$ 82,000
|
|
|
|
|
|
|
|
|
| Lessee, Finance Lease, Term of Contract (Month) |
49 months
|
|
|
|
|
|
|
|
|
| Finance Lease, Liability |
|
|
|
|
$ 450,000
|
|
$ 450,000
|
|
|
| Clyra Medical [Member] | Revolving Credit Facility [Member] | Vernal Bay Capital Group, LLC [Member] | Inventory Line of Credit [Member] |
|
|
|
|
|
|
|
|
|
| Line of Credit Facility, Monthly Percentage of Gross Product Sales Required to be Used as Payment of Debt on First 180 Days |
|
|
|
|
30.00%
|
|
30.00%
|
|
|
| Line of Credit Facility, Maximum Borrowing Capacity |
|
|
|
|
$ 1,000,000
|
|
$ 1,000,000
|
|
|
| Proceeds from Lines of Credit, Total |
|
|
|
|
|
|
260,000
|
|
|
| Repayments of Lines of Credit |
|
|
|
|
|
|
126,000
|
|
|
| Debt Instrument, Percentage of Principal Payment, Cap |
|
|
|
|
|
|
|
|
15.00%
|
| Long-Term Line of Credit |
|
|
|
$ 134,000
|
$ 134,000
|
$ 134,000
|
$ 134,000
|
|
|
| Clyra Medical [Member] | Measurement Input, Price Volatility [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding, Measurement Input |
|
|
|
21
|
|
21
|
|
|
|
| Clyra Medical [Member] | Measurement Input, Price Volatility [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding, Measurement Input |
|
|
|
0.49
|
|
0.49
|
|
|
|
| Clyra Medical [Member] | Measurement Input, Discount Rate [Member] |
|
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding, Measurement Input |
|
|
|
0.30
|
|
0.30
|
|
|
|
| Clyra Medical [Member] | Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding, Measurement Input |
|
|
|
3.95
|
3.48
|
3.95
|
3.48
|
|
|
| Clyra Medical [Member] | Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding, Measurement Input |
|
|
|
4.34
|
4.45
|
4.34
|
4.45
|
|
|
| Clyra Medical [Member] | Measurement Input, Expected Term [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding, Measurement Input |
|
|
|
0.5
|
|
0.5
|
|
|
|
| Clyra Medical [Member] | Measurement Input, Expected Term [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding, Measurement Input |
|
|
|
5
|
|
5
|
|
|
|
| Clyra Medical [Member] | Warrants Issued Concurrently with Note Payable [Member] |
|
|
|
|
|
|
|
|
|
| Debt Instrument, Interest Rate, Stated Percentage |
|
|
|
|
15.00%
|
|
15.00%
|
|
|
| Debt Instrument, Face Amount |
|
|
|
|
$ 575,000
|
|
$ 575,000
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares |
|
|
|
|
$ 6
|
|
$ 6
|
|
|
| Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares) | shares |
|
|
|
|
72,667
|
|
72,667
|
|
|
| Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares |
|
|
|
|
$ 6.5
|
|
$ 6.5
|
|
|
| Clyra Medical [Member] | Warrant In Connection With Convertible Note [Member] |
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares) | shares |
|
|
|
|
41,667
|
|
41,667
|
|
|
| Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares |
|
|
|
|
$ 7.5
|
|
$ 7.5
|
|
|
| Warrants and Rights Outstanding, Measurement Input |
|
|
|
|
6
|
|
6
|
|
|
| Clyra Medical [Member] | Warrant in Connection with Guaranteed Note [Member] |
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares) | shares |
|
|
|
|
88,462
|
|
88,462
|
|
|
| Warrants and Rights Outstanding |
|
|
|
|
$ 80,000
|
|
$ 80,000
|
|
|
| Long-Term Debt, Gross |
|
|
|
|
$ 575,000
|
|
$ 575,000
|
|
|
| Clyra Medical [Member] | Warrants Expiring February 28, 2027 [Member] |
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares |
|
|
|
|
$ 7.5
|
|
$ 7.5
|
|
|
| Warrants and Rights Outstanding |
|
|
|
$ 163,000
|
$ 45,000
|
$ 163,000
|
$ 45,000
|
|
|
| Class of Warrant or Right, Issued During Period (in shares) | shares |
|
|
|
|
36,122
|
|
|
|
|
| Number of Accredited Investors |
|
|
|
29
|
6
|
29
|
6
|
|
|
| Proceeds from Issuance or Sale of Equity |
|
|
|
|
|
$ 2,005,000
|
|
|
|
| Clyra Medical [Member] | March 31, 2025 Warrants [Member] |
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares |
|
|
|
|
$ 6
|
|
$ 6
|
|
|
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares |
|
|
|
|
5,707
|
|
5,707
|
|
|
| Warrants and Rights Outstanding, Term (Month) |
|
|
|
|
5 years
|
|
5 years
|
|
|
| Clyra Medical [Member] | Vendor Warrants [Member] |
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares |
|
|
|
|
$ 7.5
|
|
$ 7.5
|
|
|
| Warrants and Rights Outstanding |
|
|
|
|
$ 8,000
|
|
$ 8,000
|
|
|
| Warrants and Rights Outstanding, Term (Month) |
|
|
|
|
3 years
|
|
3 years
|
|
|
| Class of Warrant or Right, Issued During Period (in shares) | shares |
|
|
|
|
13,847
|
|
|
|
|
| Clyra Medical [Member] | Warrants Issued With Promissory Notes [Member] |
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares |
|
|
|
$ 6
|
|
$ 6
|
|
|
|
| Warrants and Rights Outstanding |
|
|
|
$ 160,000
|
|
$ 160,000
|
|
|
|
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares |
|
|
|
177,333
|
|
177,333
|
|
|
|
| Warrants and Rights Outstanding, Term (Month) |
|
|
|
5 years
|
|
5 years
|
|
|
|
| Clyra Medical [Member] | Saleleaseback Warrants [Member] |
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares |
|
|
|
$ 6
|
|
$ 6
|
|
|
|
| Warrants and Rights Outstanding |
|
|
|
$ 106,000
|
|
$ 106,000
|
|
|
|
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares |
|
|
|
58,333
|
|
58,333
|
|
|
|
| Warrants and Rights Outstanding, Term (Month) |
|
|
|
5 years
|
|
5 years
|
|
|
|
| Clyra Medical [Member] | Clyra Unit Offering [Member] |
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares |
|
|
|
$ 7.5
|
|
$ 7.5
|
|
|
|
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares |
|
|
|
205,670
|
|
205,670
|
|
|
|
| Clyra Medical [Member] | Notes Payable, Other Payables [Member] |
|
|
|
|
|
|
|
|
|
| Proceeds from Issuance of Debt |
|
|
|
$ 1,064,000
|
|
|
|
|
|
| Debt Instrument, Interest Rate, Stated Percentage |
|
|
|
15.00%
|
15.00%
|
15.00%
|
15.00%
|
|
|
| Debt Instrument, Face Amount |
|
|
|
|
$ 436,000
|
|
$ 436,000
|
|
|
| Warrants and Rights Outstanding |
|
|
|
|
99,000
|
|
99,000
|
|
|
| Long-Term Debt, Gross |
|
|
|
$ 864,000
|
$ 1,300,000
|
$ 864,000
|
$ 1,300,000
|
|
|
| Clyra Medical [Member] | Notes Payable, Other Payables [Member] | Biolargo [Member] |
|
|
|
|
|
|
|
|
|
| Payments to Acquire Notes Receivable |
|
|
|
$ 200,000
|
|
|
|
|
|
| Clyra Medical [Member] | Convertible Debt [Member] |
|
|
|
|
|
|
|
|
|
| Debt Instrument, Interest Rate, Stated Percentage |
|
|
|
|
15.00%
|
|
15.00%
|
|
|
| Debt Instrument, Face Amount |
|
|
|
|
$ 250,000
|
|
$ 250,000
|
|
|
| Warrants and Rights Outstanding |
|
|
|
|
$ 52,000
|
|
$ 52,000
|
|
|
| Debt Instrument, Term (Year) |
|
|
|
|
2 years
|
|
|
|
|
| Clyra Medical Technologies [Member] | Series A Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
| Stock Issued During Period, Shares, New Issues (in shares) | shares |
|
|
|
|
0
|
0
|
|
|
|
| Clyra Medical Technologies [Member] | Series B Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
| Stock Issued During Period, Shares, New Issues (in shares) | shares |
|
330,000
|
|
|
|
|
|
|
|
| Proceeds from Issuance of Preferred Stock and Preference Stock |
|
$ 2,145,000
|
|
|
|
|
|
|
|
| Clyra Medical Technologies [Member] | Warrants Issued With Secured Promissory Notes and Convertible Promissory Notes [Member] | Valuation Technique, Black-Scholes-Merton Model [Member] | Measurement Input, Price Volatility [Member] | Minimum [Member] |
|
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding, Measurement Input |
|
|
|
|
21
|
|
21
|
|
|
| Clyra Medical Technologies [Member] | Warrants Issued With Secured Promissory Notes and Convertible Promissory Notes [Member] | Valuation Technique, Black-Scholes-Merton Model [Member] | Measurement Input, Price Volatility [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding, Measurement Input |
|
|
|
|
43
|
|
43
|
|
|
| Clyra Medical Technologies [Member] | Warrants Issued in October 2025 Offering [Member] |
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares |
|
$ 7.5
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding |
|
$ 94,000
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares |
|
165,000
|
|
|
|
|
|
|
|
| Warrants and Rights Outstanding, Term (Month) |
|
3 years
|
|
|
|
|
|
|
|
| Clyra Medical Technologies [Member] | Warrant Holder Unit Offering [Member] |
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares |
|
|
|
|
$ 7.5
|
|
$ 7.5
|
|
|
| Warrants and Rights Outstanding |
|
|
|
|
$ 212,000
|
|
$ 212,000
|
|
|
| Class of Warrant or Right, Issued During Period (in shares) | shares |
|
|
|
|
336,916
|
|
|
|
|
| Number of Accredited Investors |
|
|
|
|
26
|
|
26
|
|
|
| Proceeds from Issuance or Sale of Equity |
|
|
|
|
$ 1,894,000
|
|
|
|
|
| Clyra Medical [Member] |
|
|
|
|
|
|
|
|
|
| Subsidiary, Ownership Percentage, Parent |
|
|
|
|
48.00%
|
|
48.00%
|
|
|
| Clyra Medical [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
| Investment Owned, Balance, Shares (in shares) | shares |
|
|
|
|
5,470,921
|
|
5,470,921
|
|
|
| Clyra Medical [Member] | Preferred Stock, Series A [Member] |
|
|
|
|
|
|
|
|
|
| Investment Owned, Balance, Shares (in shares) | shares |
|
|
|
|
165,765
|
|
165,765
|
|
|